Posted On: 10/21/2016 10:59:01 AM
Post# of 145278
$PTLF Hancock, MD, Oct. 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"
, a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, expands management with the addition of Dr. Simon Wood PhD, a seasoned scientist that will help expand PetLife’s product line with new patents and drugs.
Simon Wood PhD, FRSC(UK), CChem, CSci
Dr Wood is an Adjunct Professor at the University of British Columbia, Food, Nutrition and Health Program and an Adjunct Professor at the School of Public Health, Faculty of Health Sciences, Curtin University, Australia. He has over 35 years of experience gained on three continents managing chemical companies, developing proprietary natural products and their global markets and lecturing at a medical university.
https://finance.yahoo.com/news/petlife-pharma...00731.html
, a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, expands management with the addition of Dr. Simon Wood PhD, a seasoned scientist that will help expand PetLife’s product line with new patents and drugs. Simon Wood PhD, FRSC(UK), CChem, CSci
Dr Wood is an Adjunct Professor at the University of British Columbia, Food, Nutrition and Health Program and an Adjunct Professor at the School of Public Health, Faculty of Health Sciences, Curtin University, Australia. He has over 35 years of experience gained on three continents managing chemical companies, developing proprietary natural products and their global markets and lecturing at a medical university.
https://finance.yahoo.com/news/petlife-pharma...00731.html
(0)
(0)
